British Journal of Cancer published about a result of clinical research done in Hungry relating to Avemar. Several people consider it as the important formulator of view concerning cancer therapy. The Avemar is used in cancer therapy, in combination with traditional therapies.
Avemar makes direct impact on the metabolism of tumour cells. It prevents the cancer cells from reproduction and from carrying out the DNA synthesis. Then the tumour does not develop and the cancer cell dies off.
The Hungarian medical authorities registered Avemar as medical nutriment for cancer patients. In Hungary, the death rate of cancer declined when it introduced. In Czech, Bulgaria, Australia, Austria, medical authorities registered it as a medical nutriment for cancer patients.
Read